The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
The SYK tyrosine kinase: a crucial player in diverse biological functions
Open accessAbstract
Spleen tyrosine kinase (SYK) is known to have a crucial role in adaptive immune receptor signalling. However, recent reports indicate that SYK also mediates other, unexpectedly diverse biological functions, including cellular adhesion, innate immune recognition, osteoclast maturation, platelet activation and vascular development. SYK is activated by C-type lectins and integrins, and activates new targets, including the CARD9-BCL-10-MALT1 pathway and the NLRP3 inflammasome. Studies using Drosophila melanogaster suggest that there is an evolutionarily ancient origin of SYK-mediated signalling. Moreover, SYK has a crucial role in autoimmune diseases and haematological malignancies. This Review summarizes our current understanding of the diverse functions of SYK and how this is being translated for therapeutic purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“SYK is perhaps best known for the critical role that it plays in mounting protective antifungal immune responses downstream of C-type lectin (CLEC) receptors expressed on innate immune cells (Lionakis et al., 2017; Mocsai et al., 2010).”
From SYK coordinates neuroprotective microglial responses in neurodegenerative disease (2022) · cites this paper as Mocsai et al., 2010
In the citing paper
“However, recent studies indicate that it is also involved in innate immunity and non-immune functions.”
From The Role of Reactive Species on Innate Immunity (2022) · cites this paper as [96]
In the citing paper
“Upon ITAM phosphorylation, the SYK tyrosine kinase is recruited to the receptor and its activation leads to downstream phosphorylation events including activation of SHP-1 and RAC (11, 12)”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
Davis, R. E., Ngo, V. N., Lenz, G., Tolar, P., Young, R. M., Romesser, P. B., Kohlhammer, H., Lamy, L., Zhao, H., Yang, Y., et al. (2010) · Nature · doi:10.1038/nature08638 · Cited by 1,651
Signalling through C-type lectin receptors: shaping immune responses
Geijtenbeek, T. B. H., & Gringhuis, S. I. (2009) · Nature reviews. Immunology · doi:10.1038/nri2569 · Cited by 1,449
Reth, M. G. (1989) · Nature · doi:10.1038/338383b0 · Cited by 1,430
Daëron, M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.203 · Cited by 1,227
LeibundGut-Landmann, S., Groß, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1460 · Cited by 1,191
Self-citationDectin-1: a signalling non-TLR pattern-recognition receptor
Brown, G. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1745 · Cited by 1,158
Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence
Groß, O., Poeck, H., Bscheider, M., Dostert, C., Hannesschläger, N., Endres, S., Hartmann, G., Tardivel, A., Schweighoffer, E., Tybulewicz, V. L. J., et al. (2009) · Nature · doi:10.1038/nature07965 · Cited by 947
Self-citationRogers, N. C., Slack, E. M. C., Edwards, A. D., Nolte, M. A., Schulz, O., Schweighoffer, E., Williams, D. L., Gordon, S., Tybulewicz, V. L. J., Brown, G. D., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.004 · Cited by 897
Self-citation
Cited by
Sorted by citations
Items 201–300 of 1,003
Klimmeck, D., Hansson, J., Raffel, S., Vakhrushev, S. Y., Trumpp, A., & Krijgsveld, J. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.016790 · Cited by 67
Patterson, H. C., Gerbeth, C., Thiru, P., Vögtle, F. ‐., Knoll, M., Shahsafaei, A., Samocha, K. E., Huang, C. X., Harden, M. M., Song, R., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517932112 · Cited by 72
Self-citationPhosphorylation-mediated activation of mouse Xkr8 scramblase for phosphatidylserine exposure
Sakuragi, T., Kosako, H., & Nagata, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820499116 · Cited by 66
Synthetic Approaches to New Drugs Approved during 2018
Flick, A. C., Leverett, C. A., Ding, H. X., McInturff, E. L., Fink, S. J., Helal, C. J., DeForest, J. C., Morse, P., Mahapatra, S., & O’Donnell, C. J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00345 · Cited by 66
Kost‐Alimova, M., Sidhom, E.-H., Satyam, A., Chamberlain, B. T., Dvela‐Levitt, M., Melanson, M., Alper, S. L., Santos, J., Gutierrez, J., Subramanian, A., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100137 · Cited by 65
Critical role of Syk-dependent STAT1 activation in innate antiviral immunity
Liu, S., Liao, Y., Chen, B., Chen, Y., Yu, Z., Wei, H., Zhang, L., Huang, S., Rothman, P. B., Gao, G. F., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108627 · Cited by 65
Redox regulation of tyrosine kinase signalling: more than meets the eye
Dustin, C. M., Heppner, D. E., Lin, M.-C. J., & van der Vliet, A. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz085 · Cited by 67
Targeting the SYK–BTK axis for the treatment of immunological and hematological disorders
Tan, S., Liao, C., Lucas, M. C., Stevenson, C. S., & DeMartino, J. A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.02.001 · Cited by 65
Al-Harbi, N. O., Nadeem, A., Ahmad, S. F., Alanazi, M. M., Aldossari, A. A., & Alasmari, F. F. (2018) · Biochimie · doi:10.1016/j.biochi.2018.12.014 · Cited by 63
Critical role for Syk in responses to vascular injury
André, P., Morooka, T., Sim, D., Abe, K. Y., Lowell, C. A., Nanda, N., Delaney, S. M., Siu, G., Yan, Y., Hollenbach, S., et al. (2011) · Blood · doi:10.1182/blood-2011-06-360743 · Cited by 63
Quantitative Expression of C-Type Lectin Receptors in Humans and Mice
Lech, M., Susanti, H. E., Römmele, C., Gröbmayr, R., Günthner, R., & Anders, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810113 · Cited by 65
Immunoregulatory functions of immune complexes in vaccine and therapy
Wen, Y., Mu, L., & Shi, Y. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606593 · Cited by 63
Pal, P. B., Sonowal, H., Shukla, K., Sk, S., & Ramana, K. V. (2017) · Endocrinology · doi:10.1210/en.2017-00294 · Cited by 63
Corradin, O., Cohen, A. J., Luppino, J. M., Bayles, I., Schumacher, F. R., & Scacheri, P. C. (2016) · Nature Genetics · doi:10.1038/ng.3674 · Cited by 63
Scherlinger, M., Guillotin, V., Douchet, I., Vacher, P., Boizard-Moracchini, A., Guégan, J., Garreau, A., Merillon, N., Vermorel, A., Ribeiro, E., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abi4994 · Cited by 62
Mukai, T., Ishida, S., Ishikawa, R., Yoshitaka, T., Kittaka, M., Gallant, R., Lin, Y., Rottapel, R. K., Brotto, M., Reichenberger, E., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2295 · Cited by 64
The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia
Roy, C. L., Deglesne, P., Chevallier, N., Beitar, T., Éclache, V., Quettier, M., Boubaya, M., Letestu, R., Lévy, V., Cymbalista, F., et al. (2012) · Blood · doi:10.1182/blood-2011-12-397158 · Cited by 62
Novák, J., Černý, O., Osic̆ková, A., Linhartová, I., Mašín, J., Bumba, L., Šebo, P., & Osička, R. (2017) · Toxins · doi:10.3390/toxins9100300 · Cited by 62
Kurniawan, D. W., Jajoriya, A. K., Dhawan, G., Mishra, D., Argemí, J., Bataller, R. A., Storm, G., Mishra, D. P., Prakash, J., & Bansal, R. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.004 · Cited by 62
Fu, X., Zeng, H., Zhao, J., Zhou, G., Zhou, H., Zhuang, J., Xu, C., Li, J., Peng, Y., Cao, Y., et al. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00889-2 · Cited by 61
From structure to function – Ligand recognition by myeloid C-type lectin receptors
Fischer, S., Stegmann, F., Gnanapragassam, V. S., & Lepenies, B. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.10.019 · Cited by 65
Uckun, F. M., Ma, H., Zhang, J., Özer, Z., Dovat, S., Mao, C., Ishkhanian, R., Goodman, P. A., & Qazi, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209828109 · Cited by 61
Roskoski, R. J. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105579 · Cited by 62
Exploring the Impact of TREM2 in Tumor-Associated Macrophages
Khantakova, D., Brioschi, S., & Molgora, M. (2022) · Vaccines · doi:10.3390/vaccines10060943 · Cited by 69
The diverse roles of C-type lectin-like receptors in immunity
Scur, M., Parsons, B., Dey, S., & Makrigiannis, A. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1126043 · Cited by 62
Zhu, L., Luo, T.-M., Xu, X., Guo, Y., Zhao, X.-Q., Wang, T.-T., Tang, B., Jiang, Y.-Y., Xu, J., Lin, X., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151932 · Cited by 62
Liu, X., Lu, Y., Huang, J., Xing, Y., Dai, H., Zhu, L., Li, S., Feng, J., Zhou, B., Li, J., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.10.015 · Cited by 59
Anti–miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice
Zhou, Y., Abraham, S., André, P., Edelstein, L. C., Shaw, C. A., Dangelmaier, C., Tsygankov, A. Y., Kunapuli, S. P., Bray, P. F., & McKenzie, S. E. (2015) · Blood · doi:10.1182/blood-2015-02-631135 · Cited by 59
Strich, J. R., Tian, X., Samour, M., King, C. S., Shlobin, O. A., Reger, R. N., Cohen, J. B., Ahmad, K., Brown, A., Khangoora, V. S., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab732 · Cited by 59
Lhermusier, T., ROTTEM, J. V., Garcia, C., Xuereb, J.-M., Ragab, A., MARTIN, V., Gratacap, M., Siè, P., & Payrastre, B. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04470.x · Cited by 58
The many faces of FcγRI: implications for therapeutic antibody function
Swisher, J. F. A., & Feldman, G. M. (2015) · Immunological Reviews · doi:10.1111/imr.12334 · Cited by 58
Liddle, J., Atkinson, F. L., Barker, M. D., Carter, P. S., Curtis, N. R., Davis, R. P., Douault, C., Dickson, M. C., Elwes, D., Garton, N. S., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.082 · Cited by 58
Advances in Diagnosis and Treatments for Immune Thrombocytopenia
Nomura, S. (2016) · Clinical Medicine Insights Blood Disorders · doi:10.4137/cmbd.s39643 · Cited by 58
Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma
Yue, X., Ai, J., Xu, Y., Chen, Y., Huang, M., Yang, X., Hu, B., Zhang, H., He, C.-X., Yang, X., et al. (2017) · Hepatology · doi:10.1002/hep.29036 · Cited by 58
Sun, H., Lin, D., Cao, Q., Pang, B., Gae, D. D., Lee, V. K. M., Lim, H. J., Doan, N., SAID, J. W., Gery, S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2185 · Cited by 58
γδTCR recruits the Syk/PI3K axis to drive proinflammatory differentiation program
Muro, R., Nitta, T., Nakano, K., Okamura, T., Takayanagi, H., & Suzuki, H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95837 · Cited by 58
Targeting the B cell receptor pathway in non-Hodgkin lymphoma
Valla, K., Flowers, C. R., & Koff, J. L. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1482273 · Cited by 60
Wei, W., Li, X.-X., & Xu, M. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.017 · Cited by 58
The Role of PTEN in Innate and Adaptive ImmunityPreprint
Taylor, H. M., Laurence, A. D. J., & Uhlig, H. H. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036996 · Cited by 58
Serum Amyloid A Induces NLRP-3-Mediated IL-1β Secretion in Neutrophils
Migita, K., Izumi, Y., Jiuchi, Y., Kozuru, H., Kawahara, C., Nakamura, M., Nakamura, T., Agematsu, K., Masumoto, J., Yasunami, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096703 · Cited by 57
Salgado, E., Maneiro, J. R., Carmona, L., & Gómez-Reino, J. J. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203116 · Cited by 57
Saisorn, W., Saithong, S., Phuengmaung, P., Udompornpitak, K., Bhunyakarnjanarat, T., Visitchanakun, P., Charoensappakit, A., Pisitkun, P., Chiewchengchol, D., & Leelahavanichkul, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669162 · Cited by 57
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia
Wiestner, A. U. (2012) · Hematology · doi:10.1182/asheducation.v2012.1.88.3801172 · Cited by 57
Tumor cell-activated CARD9 signaling contributes to metastasis-associated macrophage polarization
Yang, M. H., Shao, J.-H., Miao, Y.-J., Cui, W., Qi, Y.-F., Jh, H., Lin, X., & Du, J. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.45 · Cited by 57
Targeting B-cell receptor signaling: changing the paradigm
Fowler, N. H., & Davis, R. E. (2013) · Hematology · doi:10.1182/asheducation-2013.1.553 · Cited by 56
Bukong, T. N., Iracheta‐Vellve, A., Saha, B., Ambade, A., Satishchandran, A., Gyöngyösi, B., Lowe, P., Catalano, D., Kodys, K., & Szabó, G. (2016) · Hepatology · doi:10.1002/hep.28680 · Cited by 56
Blomgren, P., Chandrasekhar, J., Paolo, J. A. D., Fung, W., Geng, G., Ip, C., Jones, R., Kropf, J. E., Lansdon, E. B., Lee, S. W., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00621 · Cited by 56
Onyishi, C. U., Desanti, G. E., Wilkinson, A. L., Reyna, S. J. L., Frickel, E., Fejér, G., Christophe, O. D., Bryant, C. E., Mukhopadhyay, S., Gordon, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40635-w · Cited by 58
Neutrophil heterogeneity and plasticity: unveiling the multifaceted roles in health and disease
He, W., Yan, L., Hu, D., Hao, J., Liou, Y., & Luo, G. (2025) · MedComm · doi:10.1002/mco2.70063 · Cited by 60
Sintsova, A., Sarantis, H., Islam, E. A., Sun, C., Amin, M., Chan, C. H. F., Stanners, C. P., Glogauer, M., & Gray‐Owen, S. D. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004341 · Cited by 55
McAdoo, S. P., Reynolds, J., Bhangal, G., Smith, J., McDaid, J., Tanna, A., Jackson, W. D., Masuda, E. S., Cook, H. T., Pusey, C. D., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013090978 · Cited by 55
The Syk kinase as a therapeutic target in leukemia and lymphoma
Efremov, D. G., & Laurenti, L. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.570329 · Cited by 55
DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk
Justa‐Schuch, D., Silva‐Garcia, M., Pilla, E., Engelke, M., Kilisch, M., Lenz, C., Möller, U., Nakamura, F., Urlaub, H., & Geiss‐Friedlander, R. (2016) · eLife · doi:10.7554/elife.16370 · Cited by 55
Mahon, O. R., O'Hanlon, S., Cunningham, C. C., McCarthy, G., Hobbs, C. J., Nicolosi, V., Kelly, D. J., & Dunne, A. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.10.041 · Cited by 55
Signalling for B cell survival
Schweighoffer, E., & Tybulewicz, V. L. J. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.10.002 · Cited by 55
Self-citationMcAdoo, S. P., Prendecki, M. F., Tanna, A., Bhatt, T. R., Bhangal, G., McDaid, J., Masuda, E. S., Cook, H. T., Tam, F. W. K., & Pusey, C. D. (2020) · Kidney International · doi:10.1016/j.kint.2019.12.014 · Cited by 55
PKC-Dependent Human Monocyte Adhesion Requires AMPK and Syk Activation
Chang, M.-Y., Huang, D.-Y., Ho, F.-M., Huang, K.-C., & Lin, W.-W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040999 · Cited by 54
Migdady, Y., Pang, Y., Kalsi, S. S., Childs, R., & Arai, S. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021006279 · Cited by 56
Rohila, D., Park, I. H., Pham, T. V., Weitz, J., de Mendoza, T. H., Madheswaran, S., Ishfaq, M., Beaman, C., Tapia, E., Sun, S., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3645 · Cited by 54
Spurgeon, S. E. F., Coffey, G., Fletcher, L. B., Burke, R. T., Tyner, J. W., Druker, B. J., Betz, A., DeGuzman, F. R., Pak, Y., Baker, D. C., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.200832 · Cited by 54
Nematodes and human therapeutic trials for inflammatory disease
Elliott, D. E., & Weinstock, J. V. (2016) · Parasite Immunology · doi:10.1111/pim.12407 · Cited by 55
A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism
Mansueto, M. S., Reens, A. L., Rakhilina, L., Chi, A., Pan, B., & Miller, J. R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008045 · Cited by 53
Immunoregulatory mechanism of acute kidney injury in sepsis: A Narrative Review
Sun, S., Chen, R., Dou, X., Dai, M., Long, J., Wu, Y., & Lin, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114202 · Cited by 53
Control of immune cell signaling by the immuno-metabolite itaconate
Lang, R., & Siddique, M. N. A. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1352165 · Cited by 57
Nanì, S., Fumagalli, L., Sinha, U., Kamen, L. A., Scapini, P., & Berton, G. (2014) · Journal of Innate Immunity · doi:10.1159/000365249 · Cited by 53
Regulation and Function of Syk Tyrosine Kinase in Mast Cell Signaling and Beyond
de Castro, R. O. (2011) · Journal of Signal Transduction · doi:10.1155/2011/507291 · Cited by 53
Weiss, G., Maaetoft‐Udsen, K., Stifter, S. A., Hertzog, P. J., Goriely, S., Thomsen, A. R., Paludan, S. R., & Frøkiær, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103491 · Cited by 53
Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity
Taher, T. E. I., Byström, J., Ong, V. H., Isenberg, D. A., Renaudineau, Y., Abraham, D., & Mageed, R. A. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8609-4 · Cited by 57
Hofmann, I., Geer, M. J., Vögtle, T., Crispin, A., Campagna, D. R., Barr, A., Calicchio, M. L., Heising, S., van Geffen, J. P., Kuijpers, M. J. E., et al. (2018) · Blood · doi:10.1182/blood-2017-08-802769 · Cited by 53
Immunotherapies targeting stimulatory pathways and beyond
Marin-Acevedo, J. A., Kimbrough, E. O., Manochakian, R., Zhao, Y., & Lou, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01085-3 · Cited by 52
Bernard, S., Danglade, D., Gardano, L., Laguillier, C., Lazarian, G., Roger, C., Thiéblemont, C., Marzec, J., Gribben, J. G., Cymbalista, F., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29326 · Cited by 52
Wu, S.-Y., Huang, J.-H., Chen, W.-Y., Chan, Y., Lin, C., Chen, Y., Liu, F., & Wu‐Hsieh, B. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00048 · Cited by 53
Huang, X.-R., Lin, Y., An, N., Wu, C., Wu, H.-L., Li, H., Huang, Y.-H., Ye, Q.-R., Liu, M.-D., Yang, L., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2393926 · Cited by 52
Syk Is Recruited to Stress Granules and Promotes Their Clearance through Autophagy
Krisenko, M. O., Higgins, R., Ghosh, S., Zhou, Q., Trybula, J. S., Wang, W., & Geahlen, R. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.642900 · Cited by 52
Rational Design of Highly Selective Spleen Tyrosine Kinase Inhibitors
Lucas, M. C., GOLDSTEIN, D. M., Hermann, J. C., Kuglstatter, A., Liu, W., Luk, K. C., Padilla, F., Slade, M., Villaseñor, A. G., Wanner, J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301367c · Cited by 52
Tam, F. W. K., & McAdoo, S. P. (2011) · Drugs of the Future · doi:10.1358/dof.2011.036.04.1588554 · Cited by 51
Kimura, Y., Chihara, K., Honjoh, C., Takeuchi, K., Yamauchi, S., Yoshiki, H., Fujieda, S., & Sada, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.581322 · Cited by 53
Complex phosphorylation dynamics control the composition of the Syk interactome in B cells
Bohnenberger, H., Oellerich, T., Engelke, M., Hsiao, H., Urlaub, H., & Wienands, J. (2011) · European Journal of Immunology · doi:10.1002/eji.201041326 · Cited by 50
Incrocci, R., Barse, L. W., Stone, A., Vagvala, S. H., Montesano, M., Subramaniam, V., & Swanson-Mungerson, M. A. (2016) · Virology · doi:10.1016/j.virol.2016.10.015 · Cited by 52
Hussain, A., Yu, L., Faryal, R., Mohammad, D. K., Mohamed, A. J., & Smith, C. I. E. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08134.x · Cited by 50
Syk-MyD88 Axis Is a Critical Determinant of Inflammatory-Response in Activated Macrophages
Yi, Y., Kim, H. G., Kim, J. H., Yang, W. S., Kim, E., Jeong, D., Park, J. G., Aziz, N., Kim, S., Parameswaran, N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767366 · Cited by 50
Feriotti, C., Bazan, S. B., Loures, F. V., de Araújo, E. F., da Costa, T. A., & Calich, V. L. G. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00913 · Cited by 49
Ozaki, N., Suzuki, S., Ishida, M., Harada, Y., Tanaka, K., Sato, Y., Kono, T., Kubo, M., Kitamura, D., Encinas, J., et al. (2012) · International Immunology · doi:10.1093/intimm/dxs078 · Cited by 49
Advances in the use of prodrugs for drug delivery to the eye
Taskar, P., Tatke, A., & Majumdar, S. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1208649 · Cited by 50
Moncayo, G. E., Grzmil, M., Смирнова, Т. А., Zmarz, P., Huber, R. M., Hynx, D., Kohler, H., Wang, Y., Hotz, H.-R., Hynes, N. E., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy008 · Cited by 49
Walbaum, S., Ambrosy, B., Schütz, P., Bachg, A. C., Horsthemke, M., Leusen, J. H. W., Mócsai, A., & Hanley, P. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100256 · Cited by 53
Self-citationHadas, S., Spira, M., Hanisch, U., Reichert, F., & Rotshenker, S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-166 · Cited by 49
Hatton, O. L., Phillips, L., Vaysberg, M., Hurwich, J., Krams, S. M., & Martinez, O. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.255125 · Cited by 48
Krisenko, M. O., Cartagena‐Rivera, A. X., Raman, A., & Geahlen, R. L. (2014) · Biochemistry · doi:10.1021/bi500325n · Cited by 50
Sun, S., Xue, D., Chen, Z., Ouyang, Y., Zhang, J., Mai, J., Gu, J., Lu, W., Liu, X., Liu, W., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1587-0 · Cited by 48
The uric acid crystal receptor Clec12A potentiates type I interferon responses
Li, K., Neumann, K., Duhan, V., Namineni, S., Hansen, A. L., Wartewig, T., Kurgyis, Z., Holm, C. K., Heikenwälder, M. F., Lang, K. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821351116 · Cited by 49
Self-citationBCR Signaling in Chronic Lymphocytic Leukemia and Related Inhibitors Currently in Clinical Studies
Robak, T., & Robak, P. J. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.786711 · Cited by 47
McAdoo, S. P., Bhangal, G., Page, T. H., Cook, H. T., Pusey, C. D., & Tam, F. W. K. (2015) · Kidney International · doi:10.1038/ki.2015.29 · Cited by 47
Involvement of the Syk–mTOR pathway in follicular lymphoma cell invasion and angiogenesis
Fruchon, S., Kheirallah, S., Saati, T. A., Ysebaert, L., Laurent, C., Leseux, L., Fournié, J., Laurent, G., & Bezombes, C. (2011) · Leukemia · doi:10.1038/leu.2011.248 · Cited by 47
Biswas, S., Liang, X., Panigrahi, S., Zimman, A., Wang, H., Yakubenko, V. P., Byzova, T. V., Salomon, R. G., & Podrez, E. A. (2016) · Blood · doi:10.1182/blood-2015-08-664300 · Cited by 47
SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
Poe, J. C., Jia, W., Paolo, J. A. D., Reyes, N. S., Kim, J. Y., Su, H., Sundy, J. S., Cardones, A. R., Perez, V. L., Chen, B. J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122430 · Cited by 47
IgE Autoreactivity in Atopic Dermatitis: Paving the Road for Autoimmune Diseases?
Pellefigues, C. (2020) · Antibodies · doi:10.3390/antib9030047 · Cited by 47
Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding
Gao, J., Gu, D., Yang, K., Zhang, J., Lin, Q., Yuan, W., Xu, Z., Dixit, D., Gimple, R. C., You, H., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2024.12.006 · Cited by 47
Callaway, J., Smith, S. A., McKinnon, K. P., de Silva, A. M., Crowe, J. E., & Ting, J. P. ‐. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.664136 · Cited by 46
Steevels, T. A. M., Avondt, K. V., Westerlaken, G. H. A., Stalpers, F., Walk, J., Bont, L., Coffer, P. J., & Meyaard, L. (2013) · European Journal of Immunology · doi:10.1002/eji.201242916 · Cited by 46
Metadata
- Authors
- Mócsai, A., Ruland, J., & Tybulewicz, V. L. J.
- Affiliations
- Semmelweis University (HU)
- TUM Klinikum (DE)
- National Institute for Medical Research (GB)
- Corresponding author
- Mócsai, Attila
- Venue
- Nature Reviews Immunology
- Published
- 2010-05-14
- Volume
- 10
- Issue
- 6
- Pages
- 387-402
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC4782221
- OpenAlex
- W2017341404
- Cited by
- 1,368
- References
- 194
- Citations by year
- 2026: 71 · 2025: 94 · 2024: 107 · 2023: 111 · 2022: 99 · 2021: 100 · 2020: 78 · 2019: 76 · 2018: 75 · 2017: 87 · 2016: 78 · 2015: 70 · 2014: 87 · 2013: 78 · 2012: 84
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Wellcome Trust (087782)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- Syk, innate immune recognition, C-type lectin, integrins, NLRP3 inflammasome, osteoclast maturation, bone metabolism, platelet activation, vascular development, cell adhesion, autoimmune disease, B-cell lymphoma, therapeutic target, Drosophila melanogaster
- MeSH terms
- Syk Kinase, Animals, Cell Adhesion, Humans, Protein-Tyrosine Kinases, Receptors, Immunologic, Signal Transduction, Cell Lineage, Intracellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review